Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024


BOTHELL, Wash., April 30, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's first quarter 2024 financial results will be released after market close on Thursday, May 9, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-877-346-6112 or 1-848-280-6350 for international callers. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days.

About BioLife Solutions
BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman 
Chief Financial Officer
(425) 402-1400
[email protected] 

Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
[email protected]  

SOURCE BioLife Solutions, Inc.


These press releases may also interest you

at 07:32
UniDoc Health Corp. (FRA: L7T) ("UniDoc," or the "Company"), an innovator in the eHealth sector, is excited to announce, through its partnership with UniCheck SRL, that it has been awarded as the preferred supplier for eHealth technologies in the...

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Professor Axel Lehrer, University...

at 07:30
Reese Pharmaceutical, a privately held manufacturer of over-the-counter branded and private label products today announced ColoTest®, its new Fecal Immunochemical Test (FIT) for colon cancer screening, is now available at 3,700 Walmart locations...

at 07:30
Anixa Biosciences, Inc. ("Anixa" or the "Company") , a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that treatment has commenced for the fifth patient in its ongoing Phase 1 clinical trial of...

at 07:20
InteliChart, an award-winning provider of patient engagement solutions for healthcare organizations of all sizes, proudly announced its outstanding performance in the report, InteliChart Patient Portal 2024: Providing a Best-of-Breed Patient Portal...

at 07:17
Ascent Strategy Group, the first public relations agency founded to fuel the digital health revolution, today introduced the industry's first marketing and communications tools created to guide healthcare's transformation. With its mission to advance...



News published on and distributed by: